Impact Factor 3.9 | CiteScore 4.3
More on impact ›
Precision treatments comprise pharmacological inhibitors that target a specific genetic defect or a particular pathway, but may also include therapies targeting a specific cell population, such as immunotherapies. All of these approaches exploit defined vulnerabilities of a particular disease to maximize the therapeutic window.
The mission of this section is to provide a platform for novel approaches, which optimize the precision of diagnosis and treatment that will ultimately allow us to tailor treatments for each individual patient.
Indexed in: PubMed, PubMed Central (PMC), Scopus, Google Scholar, DOAJ, CLOCKSS
PMCID: all published articles receive a PMCID
Precision Medicine welcomes submissions of the following article types: Brief Research Report, Case Report, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Study Protocol, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Precision Medicine, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com